In This Article:
Amidst a fluctuating global market landscape, marked by the return of some "Trump Trade" gains and sector-specific volatility, investors are keenly observing potential policy impacts on corporate earnings and regulatory shifts. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between a company's market price and its intrinsic value.
Top 10 Undervalued Stocks Based On Cash Flows
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Giant Biogene Holding (SEHK:2367) | HK$49.10 | HK$97.67 | 49.7% |
| Wistron (TWSE:3231) | NT$114.00 | NT$227.48 | 49.9% |
| Business First Bancshares (NasdaqGS:BFST) | US$27.67 | US$55.07 | 49.8% |
| A.L.A. società per azioni (BIT:ALA) | €24.80 | €49.51 | 49.9% |
| Telix Pharmaceuticals (ASX:TLX) | A$22.20 | A$44.23 | 49.8% |
| EnomotoLtd (TSE:6928) | ¥1481.00 | ¥2941.30 | 49.6% |
| Enento Group Oyj (HLSE:ENENTO) | €18.06 | €36.11 | 50% |
| Intermedical Care and Lab Hospital (SET:IMH) | THB4.96 | THB9.87 | 49.7% |
| Saipem (BIT:SPM) | €2.327 | €4.65 | 50% |
| Nokian Renkaat Oyj (HLSE:TYRES) | €7.39 | €14.68 | 49.7% |
We're going to check out a few of the best picks from our screener tool.
Max Estates
Overview: Max Estates Limited engages in the construction and development of residential and commercial properties, with a market cap of ₹80.07 billion.
Operations: The company's revenue is primarily derived from its Real Estate Operations & Development segment, which generated ₹1.69 billion.
Estimated Discount To Fair Value: 38.5%
Max Estates is trading significantly below its estimated fair value of ₹814.96, with a current price of ₹501.25, suggesting it may be undervalued based on cash flows. Despite past shareholder dilution, revenue grew by 47.6% last year and is expected to grow at 27.5% annually, outpacing the Indian market's growth rate of 10.5%. The company anticipates becoming profitable within three years, offering potential for substantial future earnings growth despite a low forecasted return on equity.
-
The growth report we've compiled suggests that Max Estates' future prospects could be on the up.
-
Delve into the full analysis health report here for a deeper understanding of Max Estates.
Middle East Healthcare
Overview: Middle East Healthcare Company operates a network of hospitals under the Saudi German Hospital brand in the Middle East and North Africa, with a market cap of SAR6.35 billion.
Operations: The company's revenue segments include Pharmacy Sales at SAR390.19 million, In Patient Services generating SAR1.62 billion, and Outpatient Services contributing SAR839.09 million.